SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001725160-23-000116
Filing Date
2023-05-10
Accepted
2023-05-10 07:13:15
Documents
1
Period of Report
2023-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_168371718549282.html 4  
1 FORM 4 wf-form4_168371718549282.xml 4 3531
  Complete submission text file 0001725160-23-000116.txt   5152
Mailing Address C/O ONCOTHYREON INC. 2601 FOURTH AVE, SUITE 500 SEATTLE WA 98121
Business Address
HAUSMAN DIANA (Reporting) CIK: 0001563992 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39263 | Film No.: 23904313

Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Issuer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations